Medivolve closes $12M in funding needed to support strategic plan including next phase of growth for AI technology platform that will change the face of human health management.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Marbella Pharmacy has received its initial allocation of the Johnson & Johnson vaccine
New Brand Supports Strategic Corporate Vision as “One Medivolve” Built for Transformation; Solidifying Mission to Address Gaps in the Nation’s Health System
New platform supports Medivolve’s position as a growing health technology and services company
Acquisition will give Medivolve immediate access to pharmaceutical distribution and CalVax licensing throughout CA; near term COVID-19 vaccination allocations to follow
TORONTO, May 06, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare company that seeks out disruptive technologies, ground-breaking innovations and...
New platform supports Medivolve’s position as a growing health technology and services company
Medivolve is well positioned to deliver shareholder value from its equity position in Marvel Diagnostics and the team’s successful development of BlowFISH, a non-invasive exhaled breath diagnostic technology...
TORONTO, April 30, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare investment management company that seeks out disruptive technologies, ground-breaking...